PT  - JOURNAL ARTICLE
ED  - ,
TI  - FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer
DP  - 2022 May 01
TA  - Journal of Nuclear Medicine
PG  - 13N--13N
VI  - 63
IP  - 5
4099  - http://jnm.snmjournals.org/content/63/5/13N.2.short
4100  - http://jnm.snmjournals.org/content/63/5/13N.2.full
SO  - J Nucl Med2022 May 01; 63